Bindel L, Seifert R
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40029386
DOI: 10.1007/s00210-025-03930-5.
Livadas S, Angelopoulos N, Kollias A, Paparodis R, Androulakis I, Anagnostis P
J Endocrinol Invest. 2025; .
PMID: 39899246
DOI: 10.1007/s40618-025-02543-2.
Bhandari R, Mahto P
Ann Neurosci. 2024; :09727531241282516.
PMID: 39544669
PMC: 11559499.
DOI: 10.1177/09727531241282516.
Terlea A, Toloza F, Owen R, Williams J, Knox M, Dishongh K
J Clin Med. 2024; 13(19).
PMID: 39407798
PMC: 11476508.
DOI: 10.3390/jcm13195727.
Moretti B, Livecchi R, Taylor S, Pitt S, Gay B, Haymart M
J Am Geriatr Soc. 2024; 73(2):566-573.
PMID: 39392046
PMC: 11828684.
DOI: 10.1111/jgs.19219.
Medically not yet explained symptoms in hypothyroidism.
Hegedus L, van der Feltz-Cornelis C, Papini E, Nagy E, Weetman A, Perros P
Nat Rev Endocrinol. 2024; 20(11):685-693.
PMID: 39138377
DOI: 10.1038/s41574-024-01022-7.
TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort.
Ettleson M, Penna G, Wan W, Bensenor I, Laiteerapong N, Bianco A
J Clin Endocrinol Metab. 2024; 109(12):3065-3075.
PMID: 38780968
PMC: 11570358.
DOI: 10.1210/clinem/dgae294.
Treatment of Hypothyroidism and Stress Using Neuro-Emotional Technique (NET): A Case Study.
Bablis P, Day R, Bablis S, Pollard H
Cureus. 2024; 16(4):e58231.
PMID: 38745794
PMC: 11092426.
DOI: 10.7759/cureus.58231.
EndoBridge 2023: highlights and pearls.
Yildiz B, Boguszewski C, Boguszewski M, Busetto L, Celik O, Fuleihan G
Hormones (Athens). 2024; 23(2):183-204.
PMID: 38619812
DOI: 10.1007/s42000-024-00549-8.
Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil.
Penna G, Bensenor I, Bianco A, Ettleson M
J Clin Endocrinol Metab. 2024; 109(10):2504-2512.
PMID: 38506164
PMC: 11403308.
DOI: 10.1210/clinem/dgae139.
Long-Term Outcome of Graves' Disease: A Gender Perspective.
Calissendorff J, Cramon P, Hallengren B, Khamisi S, Lantz M, Planck T
Womens Health Rep (New Rochelle). 2023; 4(1):487-496.
PMID: 37818181
PMC: 10561747.
DOI: 10.1089/whr.2023.0073.
The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis.
Xu Y, Derakhshan A, Hysaj O, Wildisen L, Ittermann T, Pingitore A
Lancet Diabetes Endocrinol. 2023; 11(10):743-754.
PMID: 37696273
PMC: 10866328.
DOI: 10.1016/S2213-8587(23)00227-9.
Over- and Undertreatment With Levothyroxine.
Alaeddin N, Jongejan R, Stingl J, de Rijke Y, Peeters R, Breteler M
Dtsch Arztebl Int. 2023; 120(42):711-718.
PMID: 37656481
PMC: 10716595.
DOI: 10.3238/arztebl.m2023.0192.
Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study.
Ayala I, Jacome C, Toro-Tobon D, Golembiewski E, Garcia-Bautista A, Hidalgo J
J Clin Endocrinol Metab. 2023; 109(2):e765-e772.
PMID: 37656124
PMC: 10795923.
DOI: 10.1210/clinem/dgad517.
The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees.
Jiang C, Wolf K, Kaakati R, Oh J, Yip A, Jonklaas J
Endocr Pract. 2023; 29(10):787-793.
PMID: 37549880
PMC: 10592164.
DOI: 10.1016/j.eprac.2023.07.031.
The Effects of Selenium Supplementation in the Treatment of Autoimmune Thyroiditis: An Overview of Systematic Reviews.
Wang Y, Liang S, Ren J, Wang Z, Deng X, Liu W
Nutrients. 2023; 15(14).
PMID: 37513612
PMC: 10386011.
DOI: 10.3390/nu15143194.
Treating subclinical hypothyroidism in individuals with or without mental health problems -A Delphi based expert consensus study in two countries.
Lieber I, Van Der Feltz-Cornelis C, Razvi S, Moriarty A, Wilkes S, Ott M
Front Endocrinol (Lausanne). 2023; 14:1204842.
PMID: 37501790
PMC: 10369346.
DOI: 10.3389/fendo.2023.1204842.
Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism?.
Casula S, Ettleson M, Bianco A
Endocr Pract. 2023; 29(7):581-588.
PMID: 37419565
PMC: 11221272.
DOI: 10.1016/j.eprac.2023.04.003.
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism.
Ettleson M, Ibarra S, Wan W, Peterson S, Laiteerapong N, Bianco A
J Clin Endocrinol Metab. 2023; 108(12):e1614-e1623.
PMID: 37327351
PMC: 10655529.
DOI: 10.1210/clinem/dgad331.
Determinants for Thyroid Hormone Replacement Therapy in Subclinical Hypothyroidism: A Multicenter Electronic Health Records-Based Study.
Toloza F, El Kawkgi O, Spencer H, Mathews S, Garcia A, Gamboa A
Thyroid. 2023; 33(9):1045-1054.
PMID: 37279296
PMC: 10516235.
DOI: 10.1089/thy.2023.0062.
